{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:22:53Z","timestamp":1791339773389,"version":"4.3.1"},"reference-count":52,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder mediated by complexes between platelet factor 4 (PF4) and heparin or other polyanions, but the risk of thrombosis extends beyond exposure to heparin implicating other PF4 partners. We recently reported that peri-thrombus endothelium is targeted by HIT antibodies, but the binding site(s) has not been identified. We now show that PF4 binds at multiple discrete sites along the surface of extended strings of von Willebrand factor (VWF) released from the endothelium following photochemical injury in an endothelialized microfluidic system under flow. The HIT-like monoclonal antibody KKO and HIT patient antibodies recognize PF4-VWF complexes, promoting platelet adhesion and enlargement of thrombi within the microfluidic channels. Platelet adhesion to the PF4-VWF-HIT antibody complexes is inhibited by antibodies that block Fc\u03b3RIIA or the glycoprotein Ib-IX complex on platelets. Disruption of PF4-VWF-HIT antibody complexes by drugs that prevent or block VWF oligomerization attenuate thrombus formation in a murine model of HIT. Together, these studies demonstrate assembly of HIT immune complexes along VWF strings released by injured endothelium that might propagate the risk of thrombosis in HIT. Disruption of PF4-VWF complex formation may provide a new therapeutic approach to HIT.<\/jats:p>","DOI":"10.1182\/blood.2018881607","type":"journal-article","created":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T15:49:40Z","timestamp":1582213780000},"page":"1270-1280","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":77,"title":["Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation"],"prefix":"10.1182","volume":"135","author":[{"given":"Ian","family":"Johnston","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Department of Pharmacology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Sarkar","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Hayes","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Departments of Pathology and Laboratory Medicine and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin T.","family":"Koma","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gowthami M.","family":"Arepally","sequence":"first","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Chen","sequence":"first","affiliation":[{"name":"Bloodworks Northwest, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic W.","family":"Chung","sequence":"first","affiliation":[{"name":"Bloodworks Northwest, Seattle, WA;"},{"name":"Departments of Medicine and Biochemistry, University of Washington, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"L\u00f3pez","sequence":"first","affiliation":[{"name":"Bloodworks Northwest, Seattle, WA;"},{"name":"Departments of Medicine and Biochemistry, University of Washington, Seattle, WA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-504X","authenticated-orcid":false,"given":"Douglas B.","family":"Cines","sequence":"first","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-3077","authenticated-orcid":false,"given":"Lubica","family":"Rauova","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mortimer","family":"Poncz","sequence":"first","affiliation":[{"name":"Division of Hematology, The Children\u2019s Hospital of Philadelphia, Philadelphia, PA;"},{"name":"Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2020040911582357900_B1","first-page":"247","article-title":"Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen","volume":"71","author":"Greinacher","year":"1994","journal-title":"Thromb Haemost"},{"issue":"6","key":"2020040911582357900_B2","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood-2005-08-3122","article-title":"Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications","volume":"107","author":"Rauova","year":"2006","journal-title":"Blood"},{"issue":"23","key":"2020040911582357900_B3","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"issue":"18","key":"2020040911582357900_B4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99445","article-title":"Neutrophil accumulation and NET release contribute to thrombosis in HIT","volume":"3","author":"Gollomp","year":"2018","journal-title":"JCI Insight"},{"issue":"10","key":"2020040911582357900_B5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198703053161004","article-title":"Immune endothelial-cell injury in heparin-associated thrombocytopenia","volume":"316","author":"Cines","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"2020040911582357900_B6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2020040911582357900_B7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/bloodadvances.2016000877","article-title":"Polyphosphate\/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia","volume":"1","author":"Cines","year":"2016","journal-title":"Blood Adv"},{"issue":"4","key":"2020040911582357900_B8","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1182\/blood-2010-08-301424","article-title":"Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia","volume":"117","author":"Krauel","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2020040911582357900_B9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2005.07.012","article-title":"Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update","volume":"118","author":"Greinacher","year":"2006","journal-title":"Thromb Res"},{"issue":"3","key":"2020040911582357900_B10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1172\/JCI90958","article-title":"Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia","volume":"127","author":"Hayes","year":"2017","journal-title":"J Clin Invest"},{"issue":"3","key":"2020040911582357900_B11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10739680590925484","article-title":"Interactions of platelets with subendothelium and endothelium","volume":"12","author":"Chen","year":"2005","journal-title":"Microcirculation"},{"issue":"3","key":"2020040911582357900_B12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch"},{"issue":"11","key":"2020040911582357900_B13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.108.187831","article-title":"The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture","volume":"104","author":"Chappell","year":"2009","journal-title":"Circ Res"},{"issue":"18","key":"2020040911582357900_B14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1161\/01.CIR.101.18.2144","article-title":"Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide","volume":"101","author":"Yang","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"2020040911582357900_B15","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1083\/jcb.142.5.1381","article-title":"Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors","volume":"142","author":"Lorenzon","year":"1998","journal-title":"J Cell Biol"},{"issue":"6","key":"2020040911582357900_B16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0025-6196(12)60522-9","article-title":"von Willebrand factor and the endothelium","volume":"66","author":"Wagner","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"suppl 1","key":"2020040911582357900_B17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion","volume":"7","author":"Sadler","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"12","key":"2020040911582357900_B18","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2020040911582357900_B19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"Chen","year":"2018","journal-title":"Blood"},{"issue":"8","key":"2020040911582357900_B20","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1182\/blood-2011-09-381400","article-title":"In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling","volume":"119","author":"Nishimura","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2020040911582357900_B21","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.4049\/jimmunol.136.5.1641","article-title":"Human monocytes and U937 cells bear two distinct Fc receptors for IgG","volume":"136","author":"Looney","year":"1986","journal-title":"J Immunol"},{"issue":"2","key":"2020040911582357900_B22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.1989.tb00258.x","article-title":"Heparin-induced thrombocytopenia: mechanism of interaction of the heparin-dependent antibody with platelets","volume":"73","author":"Chong","year":"1989","journal-title":"Br J Haematol"},{"issue":"10","key":"2020040911582357900_B23","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2003-11-3994","article-title":"Transgenic mice studies demonstrate a role for platelet factor 4 in thrombosis: dissociation between anticoagulant and antithrombotic effect of heparin","volume":"104","author":"Eslin","year":"2004","journal-title":"Blood"},{"issue":"5","key":"2020040911582357900_B24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V95.5.1533.005k01_1533_1540","article-title":"Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies","volume":"95","author":"Arepally","year":"2000","journal-title":"Blood"},{"issue":"8","key":"2020040911582357900_B25","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2020040911582357900_B26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2012-01-407262","article-title":"Dynamic antibody-binding properties in the pathogenesis of HIT","volume":"120","author":"Sachais","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2020040911582357900_B27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"2020040911582357900_B28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/jth.12511","article-title":"Effect of ADAMTS-13 on cerebrovascular microthrombosis and neuronal injury after experimental subarachnoid hemorrhage","volume":"12","author":"Muroi","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2020040911582357900_B52","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","article-title":"A practical guide to evaluating colocalization in biological microscopy","volume":"300","author":"Dunn","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"14","key":"2020040911582357900_B29","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/S0021-9258(17)33292-1","article-title":"Purification and binding properties of human platelet factor four","volume":"251","author":"Handin","year":"1976","journal-title":"J Biol Chem"},{"issue":"1","key":"2020040911582357900_B30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1182\/blood-2004-04-1544","article-title":"Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia","volume":"105","author":"Rauova","year":"2005","journal-title":"Blood"},{"issue":"26","key":"2020040911582357900_B31","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1182\/blood-2010-06-292938","article-title":"Heparin modifies the immunogenicity of positively charged proteins","volume":"116","author":"Chudasama","year":"2010","journal-title":"Blood"},{"issue":"10","key":"2020040911582357900_B32","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2011-02-335208","article-title":"Antibodies associated with heparin-induced thrombocytopenia (HIT) inhibit activated protein C generation: new insights into the prothrombotic nature of HIT","volume":"118","author":"Kowalska","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2020040911582357900_B33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V59.1.194.194","article-title":"Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4","volume":"59","author":"George","year":"1982","journal-title":"Blood"},{"issue":"4","key":"2020040911582357900_B34","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1160\/TH06-05-0274","article-title":"Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network","volume":"97","author":"Barg","year":"2007","journal-title":"Thromb Haemost"},{"issue":"19","key":"2020040911582357900_B35","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1182\/blood-2010-09-303438","article-title":"VWF self-association: more bands for the buck","volume":"116","author":"L\u00f3pez","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2020040911582357900_B36","first-page":"204","article-title":"Plasma concentration of von Willebrand factor in acute myocardial infarction","volume":"84","author":"Sakai","year":"2000","journal-title":"Thromb Haemost"},{"issue":"2","key":"2020040911582357900_B37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-2-199307150-00002","article-title":"Establishing a therapeutic range for heparin therapy","volume":"119","author":"Brill-Edwards","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"2020040911582357900_B38","first-page":"151","article-title":"Biochemistry of alpha granule proteins","volume":"22","author":"Holt","year":"1985","journal-title":"Semin Hematol"},{"issue":"1","key":"2020040911582357900_B39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng","year":"2015","journal-title":"Annu Rev Med"},{"issue":"23","key":"2020040911582357900_B40","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1182\/bloodadvances.2017009027","article-title":"Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13","volume":"1","author":"Gogia","year":"2017","journal-title":"Blood Adv"},{"issue":"4","key":"2020040911582357900_B41","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"issue":"19","key":"2020040911582357900_B42","first-page":"1","article-title":"ADAMTS13-mediated thrombolysis of tPA resistant occlusions in ischemic stroke in mice","volume":"127","author":"Denorme","year":"2017","journal-title":"Blood"},{"issue":"8","key":"2020040911582357900_B43","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood-2016-09-738856","article-title":"N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura","volume":"129","author":"Tersteeg","year":"2017","journal-title":"Blood"},{"issue":"10","key":"2020040911582357900_B44","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.autrev.2018.05.003","article-title":"Molecular and cellular pathogenesis of heparin-induced thrombocytopenia (HIT)","volume":"17","author":"Rauova","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"2020040911582357900_B45","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0741-5214(86)90390-3","article-title":"Heparin-associated thrombocytopenia and thrombosis: a serious clinical problem and potential solution","volume":"4","author":"Makhoul","year":"1986","journal-title":"J Vasc Surg"},{"issue":"8","key":"2020040911582357900_B46","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1182\/blood-2002-05-1448","article-title":"Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia","volume":"101","author":"Hong","year":"2003","journal-title":"Blood"},{"issue":"6","key":"2020040911582357900_B47","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2141.2009.08052.x","article-title":"Platelet von Willebrand factor\u2013structure, function and biological importance","volume":"148","author":"McGrath","year":"2010","journal-title":"Br J Haematol"},{"issue":"13","key":"2020040911582357900_B48","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2009-09-241547","article-title":"Expression of terminal alpha2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13","volume":"115","author":"McGrath","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2020040911582357900_B49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-3083.1998.00386.x","article-title":"High-dose intravenous immunoglobulin treatment activates complement in vivo","volume":"48","author":"Mollnes","year":"1998","journal-title":"Scand J Immunol"},{"issue":"4","key":"2020040911582357900_B50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/archsurg.1979.01370280026004","article-title":"White clot syndrome. Peripheral vascular complications of heparin therapy","volume":"114","author":"Towne","year":"1979","journal-title":"Arch Surg"},{"issue":"8","key":"2020040911582357900_B51","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/15\/1270\/1723243\/blood881607.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/135\/15\/1270\/1723243\/blood881607.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T07:59:17Z","timestamp":1695801557000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/135\/15\/1270\/452528\/Recognition-of-PF4VWF-complexes-by-heparininduced"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,9]]},"references-count":52,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2020,4,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2018881607","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,9]]}}}